| 1 |
2024 |
Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Sang-Uk Seo, Kwang Pyo Kim, Kyun-Hwan Kim. PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer, Experimental & Molecular Medicine. 2024; 56: 192.
https://doi.org/10.1038/s12276-023-01147-1 |
| 2 |
2024 |
Ling He, Hongwei Wu, Zhiqiang Sun, Jie Zhang. Inhibition of Multiple Myeloma Growth by Wogonin Involves Mitochondrial Apoptosis and G2/M Cycle Arrest, International Journal of Pharmacology. 2024; 20: 166.
https://doi.org/10.3923/ijp.2024.166.173 |
| 3 |
2022 |
Mariana Tannoury, Delphine Garnier, Santos A. Susin, Brigitte Bauvois. Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?, Cancers. 2022; 14: 6026.
https://doi.org/10.3390/cancers14246026 |
| 4 |
2023 |
Shady I. Tantawy, Natalia Timofeeva, Aloke Sarkar, Varsha Gandhi. Targeting MCL-1 protein to treat cancer: opportunities and challenges, Frontiers in Oncology. 2023; 13: 1226289.
https://doi.org/10.3389/fonc.2023.1226289 |
| 5 |
2024 |
Fatimah Alharbi, Eyad Almanifi, Md. Ashrafuzzaman. Targeting BCL-2 family proteins using BH3 mimetic drugs for cancer therapy: A systematic review of randomized clinical trials, Medicine in Drug Discovery. 2024; 24: 100199100199.
https://doi.org/10.1016/j.medidd.2024.100199 |
| 6 |
2023 |
Hongping Shen, Yiting Wei, Qunying Yang, Yili Cai, Keqi Zhu, Xueqin Chen. Scoparone induces both apoptosis and ferroptosis via multiple mechanisms in non-small-cell lung cancer cells, Toxicology in Vitro. 2023; 91: 105627105627.
https://doi.org/10.1016/j.tiv.2023.105627 |
| 7 |
2024 |
Hongguang Deng, Yu Han, Liang Liu, Hong Zhang, Dan Liu, Jiachen Wen, Min Huang, Linxiang Zhao. Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions, Journal of Medicinal Chemistry. 2024; 67: 5963.
https://doi.org/10.1021/acs.jmedchem.3c01998 |
| 8 |
2024 |
Uddalak Das, Tathagata Chanda, Jitendra Kumar, Anitha Peter. 2024;
https://doi.org/10.1101/2024.10.14.618373 |
| 9 |
2024 |
Masoumeh Vakili-Azghandi, Khalil Abnous, Ali Aliabadi, Seyed Mohammad Taghdisi, Asma Ghaemi, Mohammad Ramezani, Mona Alibolandi. Poly(2-(dimethylamino) ethyl methacrylate)-b-poly (hydroxy propyl methacrylate) nanoparticles for guided delivery of MCL-1 CRISPR-Cas9 plasmid and doxorubicin to non-small cell lung cancer, European Polymer Journal. 2024; 219: 113408113408.
https://doi.org/10.1016/j.eurpolymj.2024.113408 |
| 10 |
2023 |
Wanqing Wang, Kaipeng Jiang, Xue Liu, Ju Li, Wenshuo Zhou, Chang Wang, Jiuwei Cui, Tingting Liang. FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies, Frontiers in Pharmacology. 2023; 14: 1278056.
https://doi.org/10.3389/fphar.2023.1278056 |
| 11 |
2023 |
Wentao Bo, Yan Chen. Lenvatinib resistance mechanism and potential ways to conquer, Frontiers in Pharmacology. 2023; 14: 1153991.
https://doi.org/10.3389/fphar.2023.1153991 |
| 12 |
2023 |
Shuai Zhao, Tiantian Gu, Kaiqi Weng, Yu Zhang, Zhengfeng Cao, Yang Zhang, Wenming Zhao, Guohong Chen, Qi Xu. Phosphoproteome Reveals Extracellular Regulated Protein Kinase Phosphorylation Mediated by Mitogen-Activated Protein Kinase Kinase-Regulating Granulosa Cell Apoptosis in Broody Geese, International Journal of Molecular Sciences. 2023; 24: 12278.
https://doi.org/10.3390/ijms241512278 |
